Skip to main content
    G

    Goodrx Holdings Inc (GDRX)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $3.51
    -0.05 (-1.40%)

    Market Cap: $1.21B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Goodrx Holdings Inc (GDRX) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Goodrx Holdings (GDRX) trades at 14.6x trailing earnings and 1.5x sales. Its P/E of 14.6x is below its 5-year median of 17.5x. Its forward P/E is 10.3x. The median P/E across 8 similar companies is 35.2x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 41.7% higher over the next year. Its free cash flow yield is 11.1%.

    MultipleValue
    P/E (trailing)14.6x
    Forward P/E10.3x
    Price to sales1.5x
    Price to book1.8x
    EV/EBITDA8.3x
    Price to FCF9.0x
    EV/FCF10.5x
    PEGN/A
    FCF yield11.1%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/E14.6x17.5xN/A
    P/S1.5x2.8xN/A
    P/B1.8x2.7xN/A
    Medians of month-end values through Oct 2026: 60 months (5-year).

    Valuation History

    Over the 5 of the 6 year ends shown that have a P/E, its P/E ranged from 7.7x in 2025 to 99.0x in 2021. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$2.717.7x1.2x1.5x
    2024$4.6514.1x2.2x2.5x
    2023$6.7023.9x3.7x3.5x
    2022$4.6615.5x2.5x2.4x
    2021$32.6899.0x17.9x16.1x
    2020$40.34N/A24.4x22.8x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About GDRX

    What is GDRX's forward P/E ratio?

    Goodrx Holdings has a forward P/E ratio of 10.3x.

    Is GDRX stock overvalued?

    GNG's valuation label for GDRX is Undervalued. Its P/E of 14.6x compares with a median of 35.2x across 8 similar companies.

    What is GDRX's price to sales ratio?

    Goodrx Holdings has a price to sales ratio of 1.5x.

    What is Goodrx Holdings's average P/E ratio over 5 years?

    Goodrx Holdings's median P/E over the last 5 years is 17.5x, from 60 month-end values through Oct 2026.